Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 874–875 | Cite as

ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors

  • Apostolos Gaitanidis
  • Dhaval Patel
  • Electron KebebewEmail author
ASO Author Reflections



The authors declare that they have no conflict of interest.


  1. 1.
    Salman T, Kazaz SN, Varol U, et al. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for patients with neuroendocrine tumors: an Izmir Oncology Group Study. Chemotherapy. 2016;61(6):281–286. Scholar
  2. 2.
    Gaitanidis A, Patel D, Nilubol N, Tirosh A, Sadowski S, Kebebew E. Markers of systemic inflammatory response are prognostic factors in patients with pancreatic neuroendocrine tumors (PNETs): a prospective analysis. Ann Surg Oncol. 2018;25:122–130.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Apostolos Gaitanidis
    • 1
  • Dhaval Patel
    • 2
  • Electron Kebebew
    • 3
    Email author
  1. 1.Department of SurgeryDemocritus University of Thrace Medical SchoolAlexandroupoliGreece
  2. 2.Surgical Oncology ProgramNational Cancer InstituteBethesdaUSA
  3. 3.Department of Surgery and Stanford Cancer Institute, School of MedicineStanford UniversityStanfordUSA

Personalised recommendations